LMAT
Lemaitre Vascular Inc (LMAT)
Healthcare • NASDAQ • $107.94+0.03%
- Symbol
- LMAT
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $107.94
- Daily Change
- +0.03%
- Market Cap
- $2.47B
- Trailing P/E
- 39.68
- Forward P/E
- 33.09
- 52W High
- $118.01
- 52W Low
- $78.35
- Analyst Target
- $118.25
- Dividend Yield
- +0.92%
- Beta
- 0.60
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; X…
Company websiteResearch LMAT on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.